<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03405545</url>
  </required_header>
  <id_info>
    <org_study_id>NL62654.068.17</org_study_id>
    <nct_id>NCT03405545</nct_id>
  </id_info>
  <brief_title>High Intensity Interval Training and Skeletal Muscle Insulin Sensitivity</brief_title>
  <official_title>High Intensity Interval Training and Skeletal Muscle Insulin Sensitivity: Unraveling Health Effects and Underlying Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Netherlands Organisation for Scientific Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This human intervention study will test if supervised HIIT-based intervention improves
      skeletal muscle NOGD capacity in obese subjects. Moreover, we aim to investigate whether the
      consumption of an insulinogenic, CHO-rich drink during and after exercise prevents the
      adverse effects related to blood glucose fluctuations (energetic feelings, mood state) while
      maintaining the effect of HIIT on NOGD and promotes the adherence of the subjects to the
      training program in the long term.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      42 overweight-obese (BMI 25-35 kg/m2), sedentary females and males aged 45-65yr will be
      enrolled in this study.

      This study will be conducted in 2 randomized intervention groups;

        1. HIIT+ carbohydrate-rich beverage

        2. HIIT+ water.

      Both groups will train 3 times/week under supervision during 12 weeks (period 1) and remotely
      supervised during 40 weeks (period 2). Before, after and during each training period, there
      will be multiple metabolic measurements.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two parallel training groups</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-oxidative glucose disposal</measure>
    <time_frame>9 hours</time_frame>
    <description>Measured during a 2-step hyperinsulinemic-euglycemic clamp combined with indirect calorimetry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mood state assessed by Likert Scale, 0 to +7 score</measure>
    <time_frame>30 minutes</time_frame>
    <description>The Likert Scale is a classified as one-dimensional method assessing the degree of pleasantness and arousal as perceived by the participants. Subjects have to indicate the extent to which they agree or disagree with a series of statements. For the Likert Scale, a higher score indicates a better mood with a scale range of 0 to 84.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Energetic Feeling assessed by Chalder Fatigue Scale (CQF11).</measure>
    <time_frame>15 minutes</time_frame>
    <description>The CFQ11 is a questionnaire that assesses the extent and severity of fatigue. This questionnaire has 11 items, which are answered on a 4 points scale with a higher value indicating greater symtoms of fatigue (with a score range from 0 to 11).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle glycogen content</measure>
    <time_frame>1 hour</time_frame>
    <description>Assessed from skeletal muscle biopsies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle insulin sensitivity</measure>
    <time_frame>9 hours</time_frame>
    <description>Measured during a 2-step hyperinsulinemic-euglycemic clamp</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hour glycaemic profile</measure>
    <time_frame>48 hours</time_frame>
    <description>continuous glucose monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle mitochondrial function assessed by Magnetic Resonance Spectroscopy Scan using 31P-MRS methodology, based on the phosphocreatine (PCr) recovery kinetics after exercise.</measure>
    <time_frame>1 hour</time_frame>
    <description>The participant is positioned in the scanner with a home-built exercise device to perform consecutive knee-extensions, in which the participant has to lift a weight whilst laying in the scanner (50-60% max leg capacity of the subjects) for 5 minutes. Scout images of the upper leg are acquired and fine-tuned shimming is applied. Before, during and after exercise, spectra are acquired every 4 seconds. The restoration of PCr is driven almost purely by oxidative metabolism, the time to restore the normal amount reflects mitochondrial function (a faster restoration time means better mitochondrial function).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic Flexibility during exercise assessed by indirect calorimetry.</measure>
    <time_frame>30 minutes</time_frame>
    <description>Participants will undergo a standardized cycling test at low, moderate and high intensity (30%-50%-70%) during 10 minutes each. Throughout the test, indirect calorimetry will be performed in order to measure changes in substrate oxidation during exercise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ectopic Fat accumulation in the liver assessed by magnetic resonance spectroscopy.</measure>
    <time_frame>1 hour</time_frame>
    <description>Participants will undergo a magnetic resonance spectroscopy scan from which hepatic fat content will be quantified. In the 1H-MRS spectra, the water signal, that is dominating the proton spectra, will be suppressed using frequency-selective pre-pulse and the spectra will be fitted to quantify the lipid peak. A separate spectrum will be measured without water suppression to quantify the unsuppressed water signal. The CH2/Water ratio will be used as parameter of intrahepatic lipid content.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Acetylcarnitine formation in the upper-leg at rest and after exercise assessed by Magnetic Resonance Spectroscopy Scan</measure>
    <time_frame>1 hour</time_frame>
    <description>Magnetic resonance imaging (MRI) will be used to guide the spectroscopy measurements and fine shimming will be performed to optimize the magnetic field homogeneity within the region of interest. A volume of interest will be selected within the m. vastus lateralis from the MRI images and the 1H-MRS spectra will be acquired from this region of interest. The intensity of the creatine signal will be used as internal reference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject adherence to the HIIT training on the long-term</measure>
    <time_frame>40 weeks</time_frame>
    <description>Adherence is measured by readout of heart rate monitor used during exercise</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Obese, Pre-diabetics</condition>
  <arm_group>
    <arm_group_label>HIIT+carbohydrate-rich beverage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group of subjects will perform High Intensity Interval training while consuming a insulinogenic, carbohydrate-rich beverage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIIT+water</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group of subjects will perform High Intensity Interval training while consuming water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High-intenstiy interval training</intervention_name>
    <description>High-intensity interval training is a training of 30 minutes involving 10 bouts of 1 minute high intensity cycling (80-90% of maximum heart rate) interspersed by 2 minutes rest.</description>
    <arm_group_label>HIIT+carbohydrate-rich beverage</arm_group_label>
    <arm_group_label>HIIT+water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Insulinogenic, carbohydrate-rich drink</intervention_name>
    <description>Subject will consume a hydrolyzed casein-based drink co-ingested with maltodextrin, during and post-exercise</description>
    <arm_group_label>HIIT+carbohydrate-rich beverage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Age 45 - 65 years old

          -  Overweight to obese (BMI 25-35 kg/m2)

          -  Sedentary - subjects do not perform any regular physical activity weekly(&lt;3 times per
             week, &lt;150 min/week).

        Exclusion Criteria:

          -  Unstable body weight (weight gain or loss &gt; 3 kg in the past three months)

          -  Participation in an intensive weight-loss program or in vigorous exercise program
             during the last year before starting the study.

          -  HbA1c &gt; 6.5% and glucose clearance rate &gt;350 ml/kg/min (by OGTT).

          -  Previously diagnosed with type 2 diabetes

          -  Active cardiovascular disease. This will be determined by the questionnaires and by
             screening on medication.

          -  Use of beta-blockers

          -  Anticoagulant therapy

          -  Systolic blood pressure &gt;160 mmHg or diastolic blood pressure &gt;100 mmHg

          -  Abuse of alcohol (&gt; 3 units (1 unit = 10 gr ethanol) per day)

          -  Any contra-indication to Magnetic Resonance Imaging (MRI) scanning

          -  Participation in another biomedical study within 1 month before the first study visit,
             which may interfere with the outcomes of the present study.

          -  Use of any medication affecting the glucose homeostasis and whole body metabolism or
             diseases that may significantly interfere with the main aim of the study.

          -  Chronic renal dysfunction (creatinine &gt;2 increased (normal value 64-104 Âµmol/l)

          -  Subjects who do not want to be informed about unexpected medical findings during the
             screening / study, or do not wish that their physician is informed, cannot participate
             in the study.

          -  Subjects will be included only when the dependent medical doctor of this study
             approves participation after evaluating all data obtained during the screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthijs Hesselink, Prof. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vera Schrauwen-Hinderling, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maaike Bergman, MSc</last_name>
    <phone>0433881441</phone>
    <email>maaike.bergman@maastrichtuniversity.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rodrigo Mancilla, MSc</last_name>
    <phone>0433881493</phone>
    <email>rodrigo.mancilla@maastrichtuniversity.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Maastricht</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maaike Bergman, MSc</last_name>
      <phone>0433881441</phone>
      <email>maaike.bergman@maastrichtuniversity.nl</email>
    </contact>
    <contact_backup>
      <last_name>Rodrigo Mancilla, MSc</last_name>
      <phone>0433881493</phone>
      <email>rodrigo.mancilla@maastrichtuniversity.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>January 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

